articleTop 1% cited
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
The Lancet · 2001 · Vol. 358(9286) · pp. 958–965
Michael P. Manns✉(Medizinische Hochschule Hannover)John G. McHutchison(Scripps Clinic)Stuart C. Gordon(Beaumont Hospital, Royal Oak)Vinod K. Rustgi(Georgetown University)Mitchell L. Shiffman(Virginia Commonwealth University Medical Center)Robert ReindollarZachary Goodman(Armed Forces Institute of Pathology)Kenneth KouryMei–Hsiu LingJanice K. Albrecht
Hepatitis C virus researchLiver Disease Diagnosis and TreatmentHepatitis B Virus StudiesRibavirinMedicineGastroenterologyInternal medicinePeginterferon alfa-2aInterferon alfaHepatitis CAlpha interferonInterferonChronic hepatitis
MeSH terms
Interferon alpha-2AdultAgedDose-Response Relationship, DrugDrug Administration ScheduleDrug Therapy, CombinationFemaleGenotypeHumansMaleMiddle AgedPolyethylene GlycolsRecombinant ProteinsRibavirinRNA, Viral
Funding
- Massachusetts General Hospital
Citations
6,046
FWCI
158.98
field-weighted impact
References
22
Percentile
100%
vs. same field & year
Citations per year
Cited by
Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C
Annals of Internal Medicine · 2004 · 2,835 citations
EASL Recommendations on Treatment of Hepatitis C 2016
Journal of Hepatology · 2016 · 976 citations
EASL Recommendations on Treatment of Hepatitis C 2018
Journal of Hepatology · 2018 · 2,828 citations
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
Journal of Virology · 2002 · 1,189 citations
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
New England Journal of Medicine · 2002 · 6,389 citations
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
Journal of Hepatology · 2011 · 1,082 citations
EASL recommendations on treatment of hepatitis C: Final update of the series☆
Journal of Hepatology · 2020 · 1,185 citations
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Nature Genetics · 2009 · 2,134 citations
References
Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
Journal of General Virology · 1993 · 700 citations
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†
Hepatology · 1981 · 3,560 citations
Pegylated interferon-α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data
Clinical Pharmacology & Therapeutics · 2000 · 506 citations
Related articles
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
New England Journal of Medicine · 2002 · 6,389 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
